At the IGTP TODAY
The European Union's project THRIVE held its kick-off meeting on 12 January 2024 in Barcelona. The project is coordinated by Josep M. Llovet (IDIBAPS). IGTP collaborates as a partner through c-LOG, led by Carolina Armengol.
Researchers from B·ARGO and the Urological Tumour Unit at IGTP and ICO have led a study proposing a new therapeutic strategy based on a combination of kinase inhibitors for metastatic prostate cancer patients who have progressed on standard treatment. The study has been published in the journal Frontiers in Pharmacology.
Research teams from BSC-CNS, UPV/EHU and IGTP are working on a project that uses artificial intelligence to predict and prevent type 2 diabetes. This initiative is part of the Complementary Plan for Biotechnology Applied to Health, coordinated by IBEC.
The 'Retina Stroke Code' acts against a type of stroke that can cause irreversible vision loss if not addressed within 6 hours. It is unique in Catalonia and has proven crucial over five years for recovering visual acuity and preventing worse complications in patients at Germans Trias Hospital.
_1705911882.jpeg)
The network IMMUNO-model has brought together researchers and innovators from all over the world to foster research in immuno-oncology through the advancement in the development and implementation of pre-clinical models. This initiative is funded by the European Cooperation in Science and Technology (COST) programme.
Two studies by CEEISCAT-IGTP have evaluated an online HIV and HCV self-testing strategy, demonstrating that it is effective and safe.
The event took place at CosmoCaixa Barcelona and featured contributions from health professionals, institutions, and entities that have been collaborating closely with the centre for many years.
The IGTP Retreat consolidates as a nexus of the research carried out at the Can Ruti Campus. This year the event has focused on ageing and a patient-centred model of care.
A research team, led by Dr. Conxi Lázaro, from IDIBELL and ICO, and Dr. Eduard Serra, from IGTP, has published in the journal Molecular Oncology the expansion of a precision medicine platform to analyse and improve treatments for malignant peripheral nerve sheath tumours.
A collaborative document outlining new guidelines for the isolation and characterisation of extracellular vesicles in parasitic disease research has been published in the Journal of Extracellular Biology. A research group from IGTP and ISGlobal contributed to the study, which could enhance our understanding of host-parasite interactions and advance early diagnosis, treatment, and prevention of parasite-caused diseases.
